Characterization of Visual Characteristics in Allergic Contact Dermatitis Using the Skincam® Tool

NCT06351449 | Not Yet Recruiting

• 1 other identifier: 69HCL22_0489
• Study Type: observational
• Target: 500
• Locations: 0 countries
• Sites: N/A

Brief Summary

Contact dermatitis (CD) is a common inflammatory skin disease, affecting approximately 15-20% of the general population in industrialized countries and ranking first among occupational diseases in many European countries. The patch test method aims at reproducing the eczematous lesions by applying occlusive patches containing the suspected allergens to the patient's healthy skin. It requires experienced medical staff to read the reaction. Newtones Technologies society has developed a new tool, the SkinCam®, able to capture high resolution cross and parallel images, allowing a quantification of color and relief of skin. This study aims to illustrate patch test results, describing skin appearance (color, roughness, shine), using photographs taken by the SkinCam®.

Conditions

Allergic Contact Dermatitis

Keywords

Allergic contact dermatis (ACD); Patch Test; Photographs; SkinCams

Outcome Measures

Primary Outcomes (1)

• To highlight characteristics of allergic contact dermatitis (ACD)

  To highlight characteristics of allergic contact dermatitis (ACD), illustrating visually positive patch tests (+, ++, +++) with numerical parameters (colorimetry, shine and roughness)

  one day

Study Arms (1)

Patients with allergic contact dermatitis history

Adult patients with allergic contact dermatitis history and requiring patch test during their care pathway and accepting unidentified photographs of patch test results.

Other: The patch under study is photographed using the SkinCam®

Interventions

The patch under study is photographed using the SkinCam® OTHER

Unlike standard care, the patch under study is photographed using the SkinCam® and not a standard camera. The shooting and photographic remain similar to that of standard care, with only the camera used being changed.

Patients with allergic contact dermatitis history

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients referred for suspected contact dermatitis to the Allergology and Clinical Immunology Department of the Centre Hospitalier Lyon Sud and the Dermatology and Allergology Department of the Centre Hospitalier Universitaire de St Etienne, with allergic contact dermatitis history and requiring patch test during their care pathway

You may qualify if:

• Patient, male or female, over 18 years of age
• Patients called for reading patch test, applied 72 or 96 hours ago
• Patients agreeing to have unidentified photographs of patchs tests
• Patient affiliated to or benefiting from a social security regime
• Patient having been informed and not having opposed

You may not qualify if:

• Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision
• Pregnant woman

Sponsors & Collaborators

• Hospices Civils de Lyon: lead

MeSH Terms

Conditions

Dermatitis, Allergic Contact

Condition Hierarchy (Ancestors)

Dermatitis, Contact; Dermatitis; Skin Diseases; Skin and Connective Tissue Diseases; Skin Diseases, Eczematous; Hypersensitivity, Delayed; Hypersensitivity; Immune System Diseases

Central Study Contacts

Audrey NOSBAUM, MD

CONTACT

418861572; audrey.nosbaum@chu-lyon.fr

Florence HACARD, MD

CONTACT

4 78 86 15 72; florence.hacard@chu-lyon.fr

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 2, 2024
• First Posted: April 8, 2024
• Study Start: April 15, 2024
• Primary Completion (Estimated): April 15, 2027
• Study Completion (Estimated): April 30, 2027
• Last Updated: April 8, 2024

Record last verified: 2024-04